Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, et al: Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension. New England Journal of Medicine. 1999, 340: 677-684. 10.1056/NEJM199903043400902.
Article
CAS
PubMed
Google Scholar
Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572.
Article
CAS
PubMed
Google Scholar
Edejer TT-T: Disseminating health information in developing countries: the role of the internet. BMJ. 2000, 321: 797-800. 10.1136/bmj.321.7264.797.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J: Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011, 343: d6898-10.1136/bmj.d6898.
Article
PubMed Central
PubMed
Google Scholar
Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NRC: Cardiovascular Outcomes in Framingham Participants With Diabetes. Hypertension. 2011, 57: 891-897. 10.1161/HYPERTENSIONAHA.110.162446.
Article
PubMed Central
CAS
PubMed
Google Scholar
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine. 1998, 339: 229-234. 10.1056/NEJM199807233390404.
Article
CAS
PubMed
Google Scholar
Ghosh A, Castle PE: Invited commentary: the importance of prevalence in the effectiveness of a (bio)marker. Am J Epidemiol. 2011, 173: 1388-1390. 10.1093/aje/kwr016. discussion 1391
Article
PubMed Central
PubMed
Google Scholar
Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, et al: Severe Hypoglycemia and Risks of Vascular Events and Death. New England Journal of Medicine. 2010, 363: 1410-1418. 10.1056/NEJMoa1003795.
Article
CAS
PubMed
Google Scholar
Wang WS, Wahlqvist ML, Hsu CC, Chang HY, Chang WC, Chen CC: Age-and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health. 2012, 12: 111-10.1186/1471-2458-12-111.
Article
PubMed Central
CAS
PubMed
Google Scholar
Harati H, Hadaegh F, Saadat N, Azizi F: Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health. 2009, 9: 186-10.1186/1471-2458-9-186.
Article
PubMed Central
PubMed
Google Scholar
Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F: High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008, 8: 176-10.1186/1471-2458-8-176.
Article
PubMed Central
PubMed
Google Scholar
Gomez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gomez-Sanchez L, Rodriguez-Sanchez E, Gomez-Sanchez M, Garcia-Ortiz L: Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovascular Diabetology. 2011, 10: 90-10.1186/1475-2840-10-90.
Article
PubMed Central
CAS
PubMed
Google Scholar
Westman M, Etzion D, Danon E: Job insecurity and crossover of burnout in married couples. Journal of Organizational Behavior. 2001, 22: 467-481. 10.1002/job.91.
Article
Google Scholar
Nash ES: Teenage pregnancy-need a child bear a child. South African Medical Journal. 1990, 77: 147-151.
CAS
PubMed
Google Scholar
Trussell J: Teenage pregnancy in the United States. Family Planning Perspectives. 1988, 20: 262-272. 10.2307/2135482.
Article
CAS
PubMed
Google Scholar
Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F: Cardiovascular risk and all cause mortality attributable to diabetes: Tehran Lipid and Glucose Study. J Endocrinol Invest. 2011, 35: 14-20.
PubMed
Google Scholar
Saito I, Kokubo Y, Yamagishi K, Iso H, Inoue M, Tsugane S: Diabetes and the risk of coronary heart disease in the general Japanese population: The Japan Public Health Center-based prospective (JPHC) study. Atherosclerosis. 2011, 216: 187-191. 10.1016/j.atherosclerosis.2011.01.021.
Article
CAS
PubMed
Google Scholar
Grau M, Subirana I, Elosua R, Fitó M, Covas MI, Sala J, Masiá R, Ramos R, Solanas P, Cordon F: Why should population attributable fractions be periodically recalculated?: An example from cardiovascular risk estimation in southern Europe. Preventive medicine. 2010, 51: 78-84. 10.1016/j.ypmed.2010.03.012.
Article
PubMed
Google Scholar
Kirby D: Emerging answers 2007: Research findings on programs to reduce teen pregnancy and sexually transmitted diseases. National Campaign to Prevent Teen and Unplanned Pregnancy. Retrieved February. 2007, 23: 2009.
Google Scholar
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S: Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009, 10: 5-10.1186/1745-6215-10-5.
Article
PubMed Central
PubMed
Google Scholar
Bozorgmanesh M, Hadaegh F, Khalili D, Azizi F: Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran Lipid and Glucose Study. Cardiovascular Diabetology. 2012, 11: 20-10.1186/1475-2840-11-20.
Article
Google Scholar
Freedman DS, Kahn HS, Mei Z, Grummer-Strawn LM, Dietz WH, Srinivasan SR, Berenson GS: Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr. 2007, 86: 33-40.
CAS
PubMed
Google Scholar
Hadaegh F, Harati H, Ghanbarian A, Azizi F: Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil. 2006, 13: 571-577. 10.1097/01.hjr.0000216552.81882.ca.
Article
PubMed
Google Scholar
Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, et al: ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003, 107: 149-158. 10.1161/01.CIR.0000047041.66447.29.
Article
PubMed
Google Scholar
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, et al: ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002, 106: 1893-1900. 10.1161/01.CIR.0000037106.76139.53.
Article
PubMed
Google Scholar
Chen YQ, Hu C, Wang Y: Attributable risk function in the proportional hazards model for censored time-to-event. Biostatistics. 2006, 7: 515-10.1093/biostatistics/kxj023.
Article
PubMed
Google Scholar
Samuelsen SO, Eide GE: Attributable fractions with survival data. Statistics in Medicine. 2008, 27: 1447-1467. 10.1002/sim.3022.
Article
PubMed
Google Scholar
Silverberg MJ, Smith MW, Chmiel JS, Detels R, Margolick JB, Rinaldo CR, O’Brien SJ, Muñoz A: Fraction of Cases of Acquired Immunodeficiency Syndrome Prevented by the Interactions of Identified Restriction Gene Variants. American journal of epidemiology. 2004, 159: 232-241. 10.1093/aje/kwh036.
Article
CAS
PubMed
Google Scholar
Laaksonen MA, Knekt P, Härkänen T, Virtala E, Oja H: Estimation of the Population Attributable Fraction for Mortality in a Cohort Study Using a Piecewise Constant Hazards Model. American journal of epidemiology. 2010, 171: 837-847. 10.1093/aje/kwp457.
Article
PubMed
Google Scholar
Siadat SH, Buyut VC, Selamat H: Measuring service quality in E-retailing using SERVQUAL model. IEEE. 2008, 1-7.
Google Scholar
Liese AD, Hense H-W, Brenner H, Löwel H, Keil U: Assessing the Impact of Classical Risk Factors on Myocardial Infarction by Rate Advancement Periods. American Journal of Epidemiology. 2000, 152: 884-888. 10.1093/aje/152.9.884.
Article
CAS
PubMed
Google Scholar
Abbate LM, Stevens J, Schwartz TA, Renner JB, Helmick CG, Jordan JM: Anthropometric measures, body composition, body fat distribution, and knee osteoarthritis in women. Obesity (Silver Spring). 2006, 14: 1274-1281. 10.1038/oby.2006.145.
Article
Google Scholar
Levine B: Peer Reviewed: What Does the Population Attributable Fraction Mean?. Preventing chronic disease. 2007, 4: A14.
PubMed Central
PubMed
Google Scholar
Casiglia E, Zanette G, Mazza A, Donadon V, Donada C, Pizziol A, Tikhonoff V, Palatini P, Pessina AC: Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. European Journal of Epidemiology. 2000, 16: 677-684. 10.1023/A:1007673123716.
Article
CAS
PubMed
Google Scholar
Smith NL, Barzilay JI, Kronmal R, Lumley T, Enquobahrie D, Psaty BM: New-Onset Diabetes and Risk of All-Cause and Cardiovascular Mortality. Diabetes Care. 2006, 29: 2012-2017. 10.2337/dc06-0574.
Article
PubMed
Google Scholar
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW: Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA: The Journal of the American Medical Association. 2003, 290: 891-897. 10.1001/jama.290.7.891.
Article
PubMed
Google Scholar
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056/NEJM199807233390404.
Article
CAS
PubMed
Google Scholar
Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997, 20: 935-942. 10.2337/diacare.20.6.935.
Article
CAS
PubMed
Google Scholar
Panzram G: Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987, 30: 123-131. 10.1007/BF00274216.
Article
CAS
PubMed
Google Scholar
Stengård J, Tuomilehto J, Pekkanen J, Kivinen P, Kaarsalo E, Nissinen A, Karvonen M: Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finnish cohorts of the seven countries study. Diabetologia. 1992, 35: 760-765.
PubMed
Google Scholar
Buse JB: Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target?. No! Diabetes Care. 2003, 26: 1615-1618. 10.2337/diacare.26.5.1615.
Article
PubMed
Google Scholar
Leosdottir M, Willenheimer R, Persson M, Nilsson PM: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmö Preventive Project. Cardiovascular Diabetology. 2011, 10: 118-10.1186/1475-2840-10-118.
Article
PubMed Central
PubMed
Google Scholar
Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N: Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovascular Diabetology. 2011, 10: 1-6. 10.1186/1475-2840-10-1.
Article
Google Scholar
Liu Y, Yang Y, Zhu J, Tan H, Liang Y, Li J: Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis. Cardiovascular Diabetology. 2011, 10: 1-9. 10.1186/1475-2840-10-1.
Article
CAS
Google Scholar
Verhagen SN, Wassink AMJ, van der Graaf Y, Gorter PM, Visseren FLJ: Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study. Cardiovascular Diabetology. 2011, 10: 100-108. 10.1186/1475-2840-10-100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yadegari H, Bozorgmanesh M, Hadaegh F, Azizi F: Non-linear contribution of glucose measures to cardiovascular diseases and mortality: Reclassifying the Framingham's risk categories: A decade follow-up from the Tehran lipid and glucose study. International Journal of Cardiology. 2012, Epub ahead of print
Google Scholar
Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M: A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Significance. 2011, 8: 11.
Google Scholar
Riddle MC: Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues. Diabetes Care. 2010, 33: 2722-10.2337/dc10-1658.
Article
PubMed Central
PubMed
Google Scholar
HOOGWERF BJ: Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD. Cleveland Clinic Journal of Medicine. 2008, 75: 729-737. 10.3949/ccjm.75.10.729.
Article
PubMed
Google Scholar
Lim E, Hollingsworth K, Aribisala B, Chen M, Mathers J, Taylor R: Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011, 54: 2506-2514. 10.1007/s00125-011-2204-7.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fonseca V, Baron M, Shao Q, Dejager S: Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus. Hormone and metabolic research. 2008, 40: 427-10.1055/s-2008-1058090.
Article
CAS
PubMed
Google Scholar
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350. 10.1056/NEJM200105033441801.
Article
CAS
PubMed
Google Scholar
Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, Mirmiran P, Azizi F: Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med. 2010, 38: 628-636. 10.1016/j.amepre.2010.03.003. e621
Article
PubMed
Google Scholar
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials. Circulation. 2009, 119: 351-357. 10.1161/CIRCULATIONAHA.108.191305.
Article
PubMed
Google Scholar
Cohen A, Horton ES: Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control. Current Medical Research and Opinion. 2007, 23: 905-917. 10.1185/030079907X182068.
Article
CAS
PubMed
Google Scholar
Nesto RW, Singh PP: Diabetes and residual risk of coronary heart disease. Nat Clin Pract End Met. 2007, 3: 71-71. 10.1038/ncpendmet0398.
Article
Google Scholar